CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 45 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-03 | Vargeese Chandra Senior VP, Drug Discovery | Sale | −6,000 | $35.00 | $210K | 40,245 |
| 2019-12-03 | Vargeese Chandra Senior VP, Drug Discovery | Exercise or conversion · Share Option (right to buy) | −6,000 | 143,542 | ||
| 2019-11-20 | Verdine Gregory L. Director | Sale | −24,030 | $30.27 | $727K | 36,009 |
| 2019-11-20 | Verdine Gregory L. Director | Sale | −3,400 | $31.59 | $107K | 32,609 |
| 2019-11-20 | Verdine Gregory L. Director | Sale | −2,609 | $32.74 | $85K | 30,000 |
| 2019-09-04 | CORRIGAN MARK Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2019-09-04 | Wagner Heidi L Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2019-09-04 | Pott Amy Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2019-08-15 | Verdine Gregory L. Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2019-08-15 | HENRY CHRISTIAN O Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2019-08-15 | Rawcliffe Adrian Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2019-08-15 | TAKANASHI KEN Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2019-08-15 | Kolchinsky Peter Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2019-08-15 | Miura Koji Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2019-08-05 | Baldry Mark Chief Commerical Officer | Grant or award | +35,000 | 35,000 | ||
| 2019-08-05 | Baldry Mark Chief Commerical Officer | Grant or award | +4,000 | 39,000 | ||
| 2019-08-05 | Baldry Mark Chief Commerical Officer | Grant or award · Share Option (right to buy) | +25,000 | 25,000 | ||
| 2019-07-05 | Panzara Michael A. Chief Medical Officer | Sale | −2,613 | $26.88 | $70K | 42,775 |
| 2019-07-05 | Panzara Michael A. Chief Medical Officer | Sale | −445 | $27.26 | $12K | 42,330 |
| 2019-03-15 | BOLNO PAUL President and CEO | Exercise or conversion | +50,000 | $2.48 | $124K | 381,209 |
Page 18 of 22 · 433 trades